Literature DB >> 24516015

Maturing of renal cancer therapeutics.

Walter M Stadler1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24516015     DOI： 10.1200/JCO.2013.54.1748

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  3 in total

Review 1.  IMA901: a multi-peptide cancer vaccine for treatment of renal cell cancer.

Authors:  Alexandra Kirner; Andrea Mayer-Mokler; Carsten Reinhardt
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

Review 2.  Immunotherapy for metastatic renal cell carcinoma.

Authors:  Susanne Unverzagt; Ines Moldenhauer; Monika Nothacker; Dorothea Roßmeißl; Andreas V Hadjinicolaou; Frank Peinemann; Francesco Greco; Barbara Seliger
Journal:  Cochrane Database Syst Rev       Date:  2017-05-15

3.  MicroRNA-200c suppresses cell growth and metastasis by targeting Bmi-1 and E2F3 in renal cancer cells.

Authors:  Mingning Qiu; Ziji Liang; Lieqian Chen; Guobin Tan; Lei Liu; Kangning Wang; Hege Chen; Jianjun Liu
Journal:  Exp Ther Med       Date:  2017-02-21       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.